- €1.59bn
- €2.06bn
- €4.63bn
- 35
- 78
- 28
- 42
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,922 | 3,325 | 3,537 | 4,314 | 4,627 |
Cost of Revenue | |||||
Gross Profit | 838 | 596 | 819 | 939 | 1,006 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,726 | 3,314 | 3,378 | 4,113 | 4,436 |
Operating Profit | 196 | 11.1 | 159 | 201 | 191 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 175 | -18.5 | 133 | 188 | 171 |
Provision for Income Taxes | |||||
Net Income After Taxes | 130 | -13.9 | 84.9 | 134 | 110 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 124 | -15.8 | 83 | 131 | 112 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 124 | -15.8 | 83 | 131 | 112 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.57 | 0.641 | 1.5 | 2.18 | 2.64 |
Dividends per Share |